About Yash Pharma
Yash Pharma is a Healthcare company based in Mumbai (India) founded in 1972, and was acquired by Jagsonpal in June 2024. Its Indian entity Yash Pharma Laboratories Private Limited reported revenue of ₹46.17 Cr. Yash Pharma offers products and services including Creams and Ointments, Tablets and Capsules, Liquid Formulation, and Nasal Spray and Ear Drops. Its focus areas include Diversified Pharmaceuticals.
Company details
Architect providing design and construction services for residential projects. They offer a collaborative approach to generate nuanced solutions within complex design and regulatory environments. The firm frequently develops its own projects, gaining full exposure to the entire process from conception to implementation. This experience allows them to provide informed advice at each project phase, striving for elegant, efficient, and environmentally conscious designs.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Website yashpharma.com
- Social LinkedIn Instagram
- Acquired by Jagsonpal (Jun 2024)
- Legal Name Yash Pharma Laboratories Private Limited
- Date of Incorporation 18 Nov, 1972
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹46.17 Cr
FY 2025 · -35% YoY
- Net Profit₹31.13 Cr
FY 2025 · 67% margin
- EBITDA₹43.99 Cr
FY 2025 · 95% margin
- Latest Funding Round$523.19K (USD), Grant
Jul 2020
- InvestorsEuropean Union
& 1 more
- Acquired byJagsonpal
(Jun 2024)
Associated legal entities of Yash Pharma
Yash Pharma operates through Yash Pharma Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Yash Pharma Laboratories Private Limited CIN U24239MH1972PLC300611 | Active | 18 Nov 1972 | Thane, Maharashtra | ₹46.2 Cr | 3 | View details |
Products & Services of Yash Pharma
Yash Pharma offers a comprehensive portfolio of products and services, including Creams and Ointments, Tablets and Capsules, Liquid Formulation, and Nasal Spray and Ear Drops.
Formulations for skin care and treatment of dermatological conditions.
Medications for respiratory health and anti-fungal treatments.
Solutions for various health needs including anti-emetic applications.
Products for nasal and ear care to improve patient well-being.
Funding Insights of Yash Pharma
- Total Rounds 1
- Last Round Grant — $523,191
- First Round $523,191
(Jul 2020)
- Investors Count 1
All 1 funding rounds of Yash Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $523,191 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Yash Pharma
Yash Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Jagsonpal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Traditional company manufacturing bulk drugs and finished formulations | 1964 | jagsonpal.com | Delhi, India |
Investor details for Yash Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Yash Pharma Laboratories Private Limited (Yash Pharma)
Yash Pharma Laboratories Private Limited is the primary company behind Yash Pharma. The board of Yash Pharma Laboratories Private Limited currently have 3 directors; the longest-serving is Yashodhan Natwarlal Shah, appointed in 1972. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Yashodhan Natwarlal Shah DIN 00122220 | Managing Director | 18 Nov 1972 | 53 yrs 11 mo | Yash Pharma Laboratories Private Limited |
| Nayana Yashodhan Shah DIN 00122279 | Director | 18 Nov 1972 | 53 yrs 11 mo | Yash Pharma Laboratories Private Limited |
| Atri Yashodhan Shah DIN 00122153 | Director | 01 Nov 2002 | 23 yrs 11 mo | Yash Pharma Laboratories Private Limited |
Financials of Yash Pharma
Figures of Yash Pharma Laboratories Private Limited, the primary company behind Yash Pharma, for FY 2025. Revenue was ₹46.17 Cr (-35% year on year). Net profit was ₹31.13 Cr (67% margin). EBITDA was ₹43.99 Cr (95% margin). Revenue has grown at a compounded annual rate of -16% over three years and -10% over five years.
- ₹46.17 CrRevenue · FY 2025 · -35% YoY
- ₹31.13 CrNet profit · 67% margin
- ₹43.99 CrEBITDA · 95% margin
- ₹5.99 CrPaid-up capital
- -16%Revenue CAGR, 3 years
- -10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Yash Pharma Laboratories Private Limited are on its company page.
Detailed financial statements for Yash Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Yash Pharma
3 dated milestones of Yash Pharma across 52 years, from founding to its latest funding, stage changes and deals.
- Founded Yash Pharma is founded.
- Funding First funding round of $523K.
- Exit Acquired by Jagsonpal.
Web traffic of Yash Pharma
Websites that share an audience with Yash Pharma (yashpharma.com).
Websites whose visitors overlap most with Yash Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| merck.com | 100% | 656.8K | #78,842 | View details | |
alza.com | alza.com | 100% | – | ||
| versapharm.com | 100% | View details | |||
| meadjohnson.com | 100% | 95.7K | #413,022 | View details | |
| hiranorgochem.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Yash Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Yash Pharma
Complete news archive for Yash Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yash Pharma
Yash Pharma was founded in 1972 and raised its 1st funding round 48 years after it was founded.
Yash Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Yash Pharma, Yash Pharma Laboratories Private Limited, reported revenue of ₹46.17 Cr for FY 2025, down 35% year on year.
Architect providing design and construction services for residential projects. They offer a collaborative approach to generate nuanced solutions within complex design and regulatory environments. The firm frequently develops its own projects, gaining full exposure to the entire process from conception to implementation. This experience allows them to provide informed advice at each project phase, striving for elegant, efficient, and environmentally conscious designs.
Yash Pharma offers Creams and Ointments, Tablets and Capsules, Liquid Formulation, and Nasal Spray and Ear Drops.
Yash Pharma has 2 investors. Key investors include European Union, and Jagsonpal.
Yash Pharma operates through Yash Pharma Laboratories Private Limited.
Yes. Yash Pharma was acquired by Jagsonpal in June 2024.
The legal entities of Yash Pharma currently have 3 directors, including Atri Yashodhan Shah, Yashodhan Natwarlal Shah, Nayana Yashodhan Shah.